As I face loss of my job, and loss of my insurance, I have to reconsider whether or not I can afford my much-needed Remicade treatments. On top of everything else, I’ve already paid in $2500 of my $5000 annual out-of-pocket expenses for this year, but if I have to change to a different plan (even if it’s with the same insurance company), I have to start back at 0! Why did Obamacare never take into account those who need to change plans in the middle of the year? Is it fair for me to have to pay $7,500 this year, while everyone else on a similar plan pays $5,000? Ugh!
[Sure, why not. I just won’t eat for the next month or so.]
That was an actual call from my pharmacist after my health insurance company revised its drug formulary. Asacol HD, which I need for my ulcerative colitis, jumped from a $50 a month co-pay to the $400 a month co-pay noted above. My insurance prescription plan is three tiers – $15 for the first tier, $50 for the second tier, and 50% of the manufacturer’s price for the third tier. The third tier is generally reserved for experimental and/or non-generic drugs.
There is no generic equivalent for Asacol HD, and it used to be that if there was no generic equivalent, a drug was dropped into…
View original post 397 more words